Results for "Stem Cell Banking" in Cancer

20 articles

Brain Cancer Trial Uses Patient's Own Tumor Cells to Train Immune System
Cancer Research

Brain Cancer Trial Uses Patient's Own Tumor Cells to Train Immune System

Innovative immunotherapy approach converts patient tumor cells into personalized vaccines to fight aggressive brain cancer.

Clinical Trial
Mar 28, 2026 0
Modified T Cells Show Promise Against Childhood Blood Cancers in NCI Trial
Cancer Research

Modified T Cells Show Promise Against Childhood Blood Cancers in NCI Trial

Researchers modified children's own immune cells to fight B-cell leukemia and lymphoma when standard treatments failed.

Clinical Trial
Mar 28, 2026 0
Engineered Immune Cells Show Promise Against Advanced Cancer in Early Trial
Cancer Research

Engineered Immune Cells Show Promise Against Advanced Cancer in Early Trial

Scientists modified patients' immune cells to better recognize and attack cancer tumors expressing NY-ESO-1 protein.

Clinical Trial
Mar 28, 2026 0
CAR-T Cell Therapy Shows Promise for Treatment-Resistant Blood Cancers
Cancer Research

CAR-T Cell Therapy Shows Promise for Treatment-Resistant Blood Cancers

Small trial tests innovative immune cell therapy for patients with relapsed non-Hodgkin's lymphoma who failed standard treatments.

Clinical Trial
Mar 28, 2026 0
CAR T-Cell Therapy Shows Promise Against Relapsed Blood Cancers in Small Trial
Cancer Research

CAR T-Cell Therapy Shows Promise Against Relapsed Blood Cancers in Small Trial

Engineered immune cells target CD19+ cancer cells in patients with treatment-resistant lymphoma and leukemia.

Clinical Trial
Mar 28, 2026 1
CAR-T Cell Therapy Shows Promise Against Treatment-Resistant Multiple Myeloma
Cancer Research

CAR-T Cell Therapy Shows Promise Against Treatment-Resistant Multiple Myeloma

Genetically modified immune cells target blood cancer that stopped responding to standard treatments in 28-patient trial.

Clinical Trial
Mar 28, 2026 0
Liquid Biopsy for Sarcoma: Can cfDNA and Telomere Mutations Predict Recurrence
Cancer Research

Liquid Biopsy for Sarcoma: Can cfDNA and Telomere Mutations Predict Recurrence

Researchers explored whether cancer-derived cell-free DNA and telomere maintenance mutations could serve as early warning biomarkers in soft tissue sarcoma patients.

Clinical Trial
May 16, 2026 0
Enhanced CAR-T Cell Therapy Shows Promise Against Treatment-Resistant Blood Cancers
Cancer Research

Enhanced CAR-T Cell Therapy Shows Promise Against Treatment-Resistant Blood Cancers

Modified immune cells engineered to overcome cancer's defenses completed safety testing in lymphoma patients.

Clinical Trial
Mar 29, 2026 12
Strength Training Fights Inflammaging in Bone Marrow Transplant Survivors
Cancer Research

Strength Training Fights Inflammaging in Bone Marrow Transplant Survivors

A 10-week supervised strength program targets chronic inflammation and self-efficacy in long-term allogeneic HCT survivors.

Clinical Trial
May 25, 2026 0
Blood Test Using Exosomes Shows Promise for Monitoring Rare Sarcoma Cancers
Cancer Research

Blood Test Using Exosomes Shows Promise for Monitoring Rare Sarcoma Cancers

French study explores how tiny cellular packages in blood could predict cancer recurrence and guide treatment decisions.

Clinical Trial
Mar 28, 2026 2
Wearable Sensors Track Cancer Therapy Side Effects in Real-Time Stanford Study
Cancer Research

Wearable Sensors Track Cancer Therapy Side Effects in Real-Time Stanford Study

Stanford researchers used smartwatches and blood tests to monitor dangerous side effects during cutting-edge CAR-T cancer treatment.

Clinical Trial
Mar 29, 2026 1
CAR-T Cell Therapy Shows Promise Against Advanced Liver Cancer in Early Trial
Cancer Research

CAR-T Cell Therapy Shows Promise Against Advanced Liver Cancer in Early Trial

Engineered immune cells target liver cancer protein in phase I safety study, though trial ended early with 10 patients.

Clinical Trial
Mar 29, 2026 1
Engineered T Cells Show Promise Against Childhood Cancers in Phase I Trial
Cancer Research

Engineered T Cells Show Promise Against Childhood Cancers in Phase I Trial

Modified immune cells targeting GD2 protein demonstrated safety in treating aggressive childhood cancers like neuroblastoma and osteosarcoma.

Clinical Trial
Mar 28, 2026 0
Blood Test Detects Hidden Cancer Cells After Colorectal Surgery Using Exosomes
Cancer Research

Blood Test Detects Hidden Cancer Cells After Colorectal Surgery Using Exosomes

New liquid biopsy technique identifies molecular residual disease in colorectal cancer patients to guide personalized treatment decisions.

Clinical Trial
Mar 28, 2026 1
Trial Tests Whether Stopping Immunotherapy Early Harms NSCLC Patients Who Respond
Cancer Research

Trial Tests Whether Stopping Immunotherapy Early Harms NSCLC Patients Who Respond

A randomized Phase 2 trial investigates whether PD-1 inhibitor discontinuation after early response is safe in non-small cell lung cancer.

Clinical Trial
Jun 14, 2026 0
Natural Killer Cell Therapy Shows Promise for Advanced Cancer Treatment
Cancer Research

Natural Killer Cell Therapy Shows Promise for Advanced Cancer Treatment

Autologous NK cell therapy combined with immunotherapy tested in 27 patients with treatment-resistant cancers.

Clinical Trial
Mar 29, 2026 0
New CSF Test Could Revolutionize Brain Cancer Detection Using Exosome Analysis
Cancer Research

New CSF Test Could Revolutionize Brain Cancer Detection Using Exosome Analysis

Small study explores cerebrospinal fluid exosomes to better diagnose breast cancer spread to brain and spinal cord.

Clinical Trial
Mar 29, 2026 0
Microfluidic Chip Detects Lung Metastasis in Osteosarcoma Using Blood Exosomes
Cancer Research

Microfluidic Chip Detects Lung Metastasis in Osteosarcoma Using Blood Exosomes

New diagnostic chip analyzes blood exosomes to detect early lung spread of bone cancer, potentially improving treatment outcomes.

Clinical Trial
Mar 29, 2026 0
ISB 1442 Trial for Relapsed Multiple Myeloma Terminated Early
Cancer Research

ISB 1442 Trial for Relapsed Multiple Myeloma Terminated Early

A first-in-human Phase 1/2 trial of ISB 1442 in relapsed/refractory multiple myeloma was halted before completion.

Clinical Trial
Jun 9, 2026 0
Turin Study Maps Why Multiple Myeloma Escapes Anti-CD38 Immunotherapy
Cancer Research

Turin Study Maps Why Multiple Myeloma Escapes Anti-CD38 Immunotherapy

Italian researchers track genomic and cellular changes in myeloma patients to uncover why anti-CD38 treatments stop working.

Clinical Trial
Jun 16, 2026 0
Page 1 of 2Next